| 2024-05-15 14:47 | CC:TELO | Telo Genomics Corp (2) | 0.165 | News Release200 | Telo Genomics signs collaboration deal with Emery |
| 2024-04-10 13:44 | CC:TELO | Telo Genomics Corp (2) | 0.175 | News Release200 | Telo receives American Pathologists accreditation |
| 2024-04-02 13:23 | CC:TELO | Telo Genomics Corp (2) | 0.105 | News Release200 | Telo Genomics begins recruiting patients for MRD trial |
| 2024-02-27 16:16 | CC:TELO | Telo Genomics Corp (2) | 0.15 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-02-27 16:16 | CC:TELO | Telo Genomics Corp (2) | 0.15 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-02-13 13:23 | CC:TELO | Telo Genomics Corp (2) | 0.16 | News Release200 | Telo Genomics begins MRD clinical trial for MM patients |
| 2024-01-30 13:21 | CC:TELO | Telo Genomics Corp (2) | 0.16 | News Release200 | Telo Genomics hires Trusted Health Advisors |
| 2024-01-05 14:57 | CC:TELO | Telo Genomics Corp (2) | 0.19 | SEDAR Annual Information Form802 | SEDAR Annual Information Form |
| 2023-12-08 17:03 | CC:TELO | Telo Genomics Corp (2) | 0.17 | News Release200 | Telo Genomics CEO Weinberg resigns |
| 2023-11-22 16:40 | CC:TELO | Telo Genomics Corp (2) | 0.20 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-11-22 16:38 | CC:TELO | Telo Genomics Corp (2) | 0.20 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-11-16 14:24 | CC:TELO | Telo Genomics Corp (2) | 0.22 | News Release200 | Telo Genomics begins physician experience program |
| 2023-11-07 13:43 | CC:TELO | Telo Genomics Corp (2) | 0.21 | News Release200 | Telo proceeds to CAP accreditation assessment audit |
| 2023-11-01 13:52 | CC:TELO | Telo Genomics Corp (2) | 0.22 | News Release200 | Telo to present on TeloView-SMM at ASH meeting |
| 2023-10-30 19:23 | CC:TELO | Telo Genomics Corp (2) | 0.22 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-10-30 19:18 | CC:TELO | Telo Genomics Corp (2) | 0.22 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2023-10-26 13:11 | CC:TELO | Telo Genomics Corp (2) | 0.25 | News Release200 | Telo Genomics receives ISO accreditation |
| 2023-10-17 13:17 | CC:TELO | Telo Genomics Corp (2) | 0.23 | News Release200 | Telo rolls out TeloViewSMM for U.S. clinicians |
| 2023-09-06 15:09 | CC:TELO | Telo Genomics Corp (2) | 0.30 | News Release200 | Telo Genomics obtains ISO 15189 accreditation |
| 2023-08-29 17:05 | CC:TELO | Telo Genomics Corp (2) | 0.27 | News Release200 | Telo Genomics working toward TeloView-SMM release in Q4 |
| 2023-07-18 18:19 | CC:TELO | Telo Genomics Corp (2) | 0.26 | Shares for Debt330 | Telo Genomics 150,000 shares for services |
| 2023-06-30 13:21 | CC:TELO | Telo Genomics Corp (2) | 0.295 | News Release200 | Telo Genomics to issue 150,000 shares for services |
| 2023-06-20 18:23 | CC:TELO | Telo Genomics Corp (2) | 0.30 | Private Placement250 | Telo Genomics 11,335,500-share private placement |
| 2023-06-14 15:17 | CC:TELO | Telo Genomics Corp (2) | 0.30 | News Release200 | Telo Genomics closes $2.83-million private placement |
| 2023-06-12 11:26 | CC:TELO | Telo Genomics Corp (2) | 0.29 | News Release200 | Telo talks MM drug resistance study at EHA 2023 |
| 2023-06-06 17:05 | CC:TELO | Telo Genomics Corp (2) | 0.30 | News Release200 | Telo Genomics increases placement to $2.76-million |
| 2023-06-05 15:36 | CC:TELO | Telo Genomics Corp (2) | 0.305 | News Release200 | Telo presents multiple myeloma studies results |
| 2023-05-19 10:08 | CC:TELO | Telo Genomics Corp (2) | 0.30 | News Release200 | Telo Genomics arranges $2M private placement |
| 2023-05-18 16:59 | CC:TELO | Telo Genomics Corp (2) | 0.30 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-05-18 16:53 | CC:TELO | Telo Genomics Corp (2) | 0.30 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |